Brain Glutathione Levels and Negative Symptoms in Schizophrenia
Author Information
Author(s): Matsuzawa Daisuke, Obata Takayuki, Shirayama Yukihiko, Nonaka Hiroi, Kanazawa Yoko, Yoshitome Eiji, Takanashi Junichi, Matsuda Tsuyoshi, Shimizu Eiji, Ikehira Hiroo, Iyo Masaomi, Hashimoto Kenji
Primary Institution: Chiba University Graduate School of Medicine
Hypothesis
Are GSH levels altered in the posterior medial frontal cortex of schizophrenic patients, and how do they correlate with clinical variables?
Conclusion
GSH levels in the posterior medial frontal cortex may be related to negative symptoms in schizophrenic patients.
Supporting Evidence
- GSH levels in the posterior medial frontal cortex were not different from those of normal controls.
- There was a significant negative correlation between GSH levels and the severity of negative symptoms.
- Four subscales of negative symptoms showed significant negative correlations with GSH levels.
Takeaway
This study found that lower levels of a brain chemical called GSH are linked to worse symptoms in people with schizophrenia.
Methodology
The study measured GSH levels in the brains of 20 schizophrenia patients and 16 normal controls using 3T 1H-MRS and assessed clinical variables with various scales.
Potential Biases
Potential bias due to medication effects on GSH levels.
Limitations
The study had a small sample size and was limited to specific brain regions.
Participant Demographics
20 schizophrenia patients and 16 age- and gender-matched normal controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website